{"@context":{"@vocab":"https://schema.org/"},"@type":"Legislation","@id":"https://api.ai-analytics.org/trade-case/2308#inv","name":"Advice Concerning the Addition of Certain Pharmaceutical Products and Chemical Intermediates to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of the United States, Inv. 332-405","legislationIdentifier":"332-402","datePublished":"1999-01-15","description":"USITC Factfinding investigation 332-402 — Advice Concerning the Addition of Certain Pharmaceutical Products and Chemical Intermediates to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of the United States. Concluded 1999-04-01.","url":"https://ids.usitc.gov/case/6478/investigation/2308","isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","investigation":{"investigation_id":2308,"investigation_number":"332-402","case_class":"FACTFINDING","type":"Factfinding (Industry and Economic Analysis)","title":"Advice Concerning the Addition of Certain Pharmaceutical Products and Chemical Intermediates to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of the United States, Inv. 332-405","product":"Advice Concerning the Addition of Certain Pharmaceutical Products and Chemical Intermediates to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of the United States","phase":"Final 1","start_date":"1999-01-15","end_date":"1999-04-01","active":false,"ids_url":"https://ids.usitc.gov/case/6478/investigation/2308","url":"https://api.ai-analytics.org/trade-case/2308"},"_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://ids.usitc.gov/","primary_source_dataset":"USITC Investigations Database System (IDS)","generated_at":"2026-06-26T17:46:32.284Z"}}